Citius Pharmaceuticals (CTXR) FDA Approvals - MarketBeat
5 days ago · Mino-Lok is a drug developed by Citius Pharmaceuticals for the following indication: Catheter-related bloodstream infections (CRBSIs). This drug is under review by the U.S. Food and …
Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle …
3 days ago · Citius Pharma's late-stage pipeline also includes Mino-Lok ®, a catheter lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), …
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR
5 days ago · Citius Pharma's late-stage pipeline also includes Mino-Lok ®, a catheter lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), …
Citius Pharmaceuticals Highlights Oncology Pipeline and LYMPHIR …
5 days ago · Other programs featured include Mino-Lok®, a treatment designed to salvage infected catheters causing central line-associated bloodstream infections (CLABSI), which has completed a …
Citius Pharmaceuticals (CTXR) Company Profile & Description
3 days ago · The company’s late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical …
Corporate Presentation (Citius Pharmaceuticals Inc) - Steel.com
6 days ago · ) CD (CNPoEiAhrCtpiSEaouDMrrasmABteQE Biopharmaceutical company with multiple advanced development programs LYMPHIR (denileukin diftitox-cxdl) LAUNCHED December 2025 …
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR, a …
5 days ago · Citius Pharma's late-stage pipeline also includes Mino-Lok (R), a catheter lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), …
Stockwatch
3 days ago · Citius Pharma's late-stage pipeline also includes Mino-Lok ®, a catheter lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), …
CTXR: Analyst Jason Kolbert Maintains 'Buy' Rating with $6 Price
3 days ago · Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander …
Citius Pharmaceuticals (CTXR) Stock Price & Overview
2 days ago · Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAE LYMPHIR international …